Pfizer Inc logo

PFE - Pfizer Inc Share Price

$40.51 -0.1  -0.2%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £172.35bn
Enterprise Value £206.08bn
Revenue £39.78bn
Position in Universe 34th / 6410
Bullish
Bearish
Unlock PFE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PFE Revenue Unlock PFE Revenue

Net Income

PFE Net Income Unlock PFE Revenue

Normalised EPS

PFE Normalised EPS Unlock PFE Revenue

PE Ratio Range

PFE PE Ratio Range Unlock PFE Revenue

Dividend Yield Range

PFE Dividend Yield Range Unlock PFE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PFE EPS Forecasts Unlock PFE Revenue
Profile Summary

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated June 2, 1942
Public Since January 17, 1944
No. of Shareholders: 150,398
No. of Employees: 92,400
Sector Healthcare
Industry Pharmaceuticals
Index Dow Jones Composite , Dow Jones Industrial Average , FTSE Global 100, S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 5,534,122,364
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PFE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PFE
Upcoming Events for PFE
Similar to PFE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.